CMPD: Cancer mutant proteome database

Po Jung Huang, Chi Ching Lee, Bertrand Chin Ming Tan, Yuan Ming Yeh, Lichieh Julie Chu, Ting-Wen Chen, Kai Ping Chang, Cheng Yang Lee, Ruei Chi Gan, Hsuan Liu, Petrus Tang*


研究成果: Article同行評審

13 引文 斯高帕斯(Scopus)


Whole-exome sequencing, which centres on the protein coding regions of disease/cancer associated genes, represents the most cost-effective method to-date for deciphering the association between genetic alterations and diseases. Large-scale whole exome/genome sequencing projects have been launched by various institutions, such as NCI, Broad Institute and TCGA, to provide a comprehensive catalogue of coding variants in diverse tissue samples and cell lines. Further functional and clinical interrogation of these sequence variations must rely on extensive cross-platforms integration of sequencing information and a proteome database that explicitly and comprehensively archives the corresponding mutated peptide sequences. While such data resource is a critical for the mass spectrometrybased proteomic analysis of exomic variants, no database is currently available for the collection of mutant protein sequences that correspond to recent large-scale genomic data. To address this issue and serve as bridge to integrate genomic and proteomics datasets, CMPD ( collected over 2 millions genetic alterations, which not only facilitates the confirmation and examination of potential cancer biomarkers but also provides an invaluable resource for translational medicine research and opportunities to identify mutated proteins encoded by mutated genes.

頁(從 - 到)D849-D855
期刊Nucleic acids research
出版狀態Published - 28 1月 2015


深入研究「CMPD: Cancer mutant proteome database」主題。共同形成了獨特的指紋。